v3.25.2
COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS COMMON STOCK OFFERING, RESTRICTED STOCK UNITS, STOCK OPTIONS AND WARRANTS 
Common Stock Repurchased

During the three and six months ended June 30, 2025 and 2024, the Company did not acquire any shares of its Common Stock on the open market.

Stock Plan

The Company’s stock plan consists of the 2013 Equity Incentive Plan, as amended and restated in July 2017 (the “2013 Plan”). On February 26, 2025, pursuant to the “evergreen” provisions of the 2013 Plan, the Board of Directors authorized an increase of approximately 3.6 million shares available for grant under the 2013 Plan.

On March 4, 2025, the Company’s Board of Directors approved the Company’s 2025 Long-Term Incentive Plan (the “2025 LTI Plan”), consisting of awards of performance units (“PSUs”), restricted stock units (“RSUs”) and stock options to purchase shares of the Company’s Common Stock under the terms of the Company’s 2013 Plan, as amended, effective March 4, 2025.

On May 3, 2024, the Company’s Board of Directors approved the Company’s 2024 Long-Term Incentive Plan (the “2024 LTI Plan”), consisting of awards of PSUs, RSUs and stock options to purchase shares of the Company’s Common Stock under the terms of the Company’s 2013 Plan, as amended, effective May 6, 2024.

For additional information about the 2013 Plan, please refer to Note 7 to the Company’s Consolidated Financial Statements for the year ended December 31, 2024, included in Part II, Item 8 of the 2024 Form 10-K. The information presented below provides an update for activity under the 2013 Plan for the three and six months ended June 30, 2025.

Performance Units

Under the 2025 LTI Plan, the Company granted PSUs which will be measured over a performance period beginning on January 1, 2025 and ending on December 31, 2025 (the “Performance Period”), but will remain subject to a continued service-based vesting requirement. Half of the PSUs awarded are eligible to vest based on the Company’s achievement against a target adjusted EBITDA goal for fiscal year 2025, and the remaining half of the PSUs awarded will be eligible to vest based on the Company’s achievement against a target total revenue goal for fiscal year 2025. The ultimate number of PSUs that may vest (as calculated, the “Earned PSUs”) range from zero to 200% of the granted PSUs. On March 4, 2025, the Company granted 0.6 million PSUs at a grant price of $3.48.

The Earned PSUs under the May 6, 2024 grant were earned at 28%. Under the terms of the 2024 LTI Plan, the Earned PSUs will vest in equal annual installments on the first, second and third anniversaries of the Date of Grant, generally subject to the awardee continuing to be a Service Provider through the applicable vesting date.

The Earned PSUs under the April 3, 2023 grant were earned at 151%. Under the terms of the 2023 LTI Plan, the Earned PSUs will vest in equal annual installments on the first, second and third anniversaries of the Date of Grant, generally subject to the awardee continuing to be a Service Provider through the applicable vesting date.

The Company recognized compensation expense related to PSUs of $0.4 million and $0.2 million for the three months ended June 30, 2025 and 2024, respectively. For the six months ended June 30, 2025 and 2024, the Company recognized compensation expense related to PSUs of $0.8 million and $0.8 million, respectively. As of June 30, 2025, the unrecognized expense of $1.9 million net of forfeitures is expected to be charged to expense on a graded basis as the PSUs vest over a weighted-average period of approximately 2 years.
 
Restricted Stock Units
 
For the six months ended June 30, 2025, the Company granted RSUs under the 2013 Plan to employees and to non-employee members of the Company’s Board of Directors for an aggregate of approximately 1.1 million shares of Common Stock. RSU grants vest over periods generally ranging from 12 to 36 months from the respective grant dates and the awards are subject to forfeiture upon termination of employment or service on the Board of Directors, as applicable. Based on the weighted average fair market value of the Common Stock on the date of grant of $3.41 per share, the aggregate fair value for the shares underlying the RSUs amounted to $3.7 million as of the grant date that will be recognized as compensation cost over the vesting period.
For the three months ended June 30, 2025 and 2024, the Company recognized compensation expense related to RSUs of approximately $1.5 million and $1.4 million, respectively. For the six months ended June 30, 2025 and 2024, the Company recognized compensation expense related to RSUs of approximately $2.9 million and $2.6 million, respectively. As of June 30, 2025, the unrecognized expense of $9.8 million net of forfeitures is expected to be charged to expense on a straight-line basis as the RSUs vest over a weighted-average period of approximately 2.2 years.
 
Stock Options
 
For the six months ended June 30, 2025, the Company granted stock options for the purchase of an aggregate of approximately 0.9 million shares of Common Stock at exercise prices that were equal to the fair market value of the Common Stock on the date of grant. Options granted to employees generally vest as to one-third of the shares subject to the award on each anniversary of the designated vesting commencement date, which may precede the grant date of such award, and expire ten years after the grant date.
 
The following table sets forth a summary of stock option activity under the 2013 Plan for the six months ended June 30, 2025 (shares in thousands): 
 Shares
Price (1)
Term (2)
Outstanding, December 31, 20249,563 $4.68 6.9
Granted867 3.44 
Exercised(3)2.63 
Forfeited(92)3.14 
Expired(671)5.62 
Outstanding, June 30, 2025 (3)(4)9,664 4.52 7.1
Vested, June 30, 2025 (3)5,046 5.91 5.2
 
(1)Represents the weighted average exercise price.
(2)Represents the weighted average remaining contractual term until the stock options expire in years.
(3)As of June 30, 2025, the aggregate intrinsic value of all stock options outstanding was $4.2 million. As of June 30, 2025, there was an aggregate intrinsic value of $0.4 million related to the vested stock options.
(4)The number of outstanding stock options that are not expected to ultimately vest due to forfeiture amounted to 0.6 million shares as of June 30, 2025.
 
The aggregate fair value of approximately 0.9 million stock options granted for the six months ended June 30, 2025 amounted to $1.9 million, or $2.16 per stock option as of the grant date utilizing the Black-Scholes-Merton (“BSM”) method. The fair valued derived under the BSM method will result in the recognition of compensation cost over the vesting period of the stock options. For the six months ended June 30, 2025, the fair value of each stock option grant under the 2013 Plan was estimated on the date of grant using the BSM option-pricing model, with the following weighted-average assumptions:
 
Expected life (in years)6.0
Volatility66%
Dividend yield0%
Risk-free interest rate4.1%
Fair value per share of Common Stock on date of grant$3.44
 
As of June 30, 2025 and December 31, 2024, total unrecognized compensation costs related to unvested stock options, net of estimated forfeitures, was $6.0 million and $5.7 million, respectively. As of June 30, 2025, the unrecognized costs are expected to be charged to expense on a straight-line basis over a weighted-average vesting period of approximately 2.2 years.
Shares Available for Grant

The following table presents activity affecting the total number of shares available for grant under the 2013 Plan for the six months ended June 30, 2025 (in thousands):
 
Available, December 31, 20245,379 
Newly authorized by Board of Directors3,645 
Stock options granted(867)
RSUs and PSUs granted(1,671)
Expired options671 
Forfeited options92 
Forfeited RSUs and PSUs665 
Available, June 30, 20257,914 
 
Stock-Based Compensation Expense
 
Stock-based compensation expense attributable to PSUs, RSUs and stock options is classified as follows (in thousands):
Three Months Ended
June 30,
Six Months Ended June 30,
 2025202420252024
Cost of revenue$490 $460 $1,014 $975 
Sales and marketing1,028 576 1,954 980 
General and administrative1,355 1,369 2,607 3,008 
Total$2,873 $2,405 $5,575 $4,963 

Warrants
 
As of June 30, 2025, warrants were outstanding for an aggregate of 3.4 million shares of Common Stock exercisable at $5.64 per share. For additional information about these warrants, please refer to Note 7 to the Company’s Consolidated Financial Statements for the year ended December 31, 2024, included in Part II, Item 8 of the 2024 Form 10-K.